Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2023; 56(02): 173-177
DOI: 10.1055/s-0043-1761182
Case Report

First Case Report of Breast Implant Associated-Anaplastic Large Cell Lymphoma from India: Are We Ready?

Soumya Khanna
1   Plastic & Reconstructive Surgery, Max Institute of Reconstructive, Aesthetic, Cleft and Craniofacial Surgery, Max Superspeciality Hospital, Saket, New Delhi, India
,
Sunil Choudhary 
1   Plastic & Reconstructive Surgery, Max Institute of Reconstructive, Aesthetic, Cleft and Craniofacial Surgery, Max Superspeciality Hospital, Saket, New Delhi, India
,
Raghav Mantri
1   Plastic & Reconstructive Surgery, Max Institute of Reconstructive, Aesthetic, Cleft and Craniofacial Surgery, Max Superspeciality Hospital, Saket, New Delhi, India
,
Prateek Arora
1   Plastic & Reconstructive Surgery, Max Institute of Reconstructive, Aesthetic, Cleft and Craniofacial Surgery, Max Superspeciality Hospital, Saket, New Delhi, India
,
Anupama Arya
2   Department of Pathology, Max Superspeciality Hospital, Saket, New Delhi, India
,
Richa Bansal
3   Department of Radiology, Max Superspeciality Hospital, Saket, New Delhi, India
,
Preeti Grewal
1   Plastic & Reconstructive Surgery, Max Institute of Reconstructive, Aesthetic, Cleft and Craniofacial Surgery, Max Superspeciality Hospital, Saket, New Delhi, India
,
Nishu Bhardawaj
2   Department of Pathology, Max Superspeciality Hospital, Saket, New Delhi, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) has become a hot topic in recent plastic surgery and oncology forum. Its cases have been on the rise since its first emergence more than two decades ago. This condition is less known and management guidelines are still evolving. BIA-ALCL was seen recently with a classical presentation in one of our patients, who underwent immediate reconstruction with a macro-textured silicone implant following breast cancer surgery. We want to add the first case report from India to the global information database. There are still unanswered questions in its management, and we wish to highlight the same to make way for further research. With the rise in aesthetic and reconstructive implant surgeries, the knowledge of BIA-ALCL must expand among oncologists, radiologists, and pathologists for early identification and treatment for better patient outcomes.

Keywords

breast implant associated-anaplastic large cell lymphoma - breast implant lymphoma - BIA-ALCL in India


Publication History

Article published online:
21 February 2023

© 2023. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 2019; 143 (3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 30S-40S
    CrossrefPubMedGoogle Scholar
  • 2 Swanson E. Concerns regarding dishonesty in reporting a large study of patients treated with allergan Biocell breast implants. Ann Plast Surg 2022; 88 (06) 585-588
    CrossrefPubMedGoogle Scholar
  • 3 Keech Jr JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100 (02) 554-555
    PubMedGoogle Scholar
  • 4 Ohishi Y, Mitsuda A, Ejima K. et al. Breast implant-associated anaplastic large-cell lymphoma: first case detected in a Japanese breast cancer patient. Breast Cancer 2020; 27 (03) 499-504
    CrossrefPubMedGoogle Scholar
  • 5 Lai CS, Wu CY, Chen IC, Tsai YC. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) - the first case in Taiwan. Asian J Surg 2021; 44 (06) 869-870
    CrossrefPubMedGoogle Scholar
  • 6 Wang Y, Zhang Q, Tan Y. et al. Current progress in breast implant-associated anaplastic large cell lymphoma. Front Oncol 2022; 11: 785887
    CrossrefPubMedGoogle Scholar
  • 7 Cordeiro PG, Ghione P, Ni A. et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg 2020; 73 (05) 841-846
    CrossrefPubMedGoogle Scholar
  • 8 Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J 2019; 39 (Suppl 1): S3-S13
    CrossrefPubMedGoogle Scholar
  • 9 Lajevardi SS, Rastogi P, Isacson D, Deva AK. What are the likely causes of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)?. JPRAS Open 2022; 32: 34-42
    CrossrefPubMedGoogle Scholar
  • 10 Walker JN, Hanson BM, Pinkner CL. et al. Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma. Sci Rep 2019; 9 (01) 10393
    CrossrefPubMedGoogle Scholar
  • 11 Julien L-A, Michel RP, Auger M. Breast implant-associated anaplastic large cell lymphoma and effusions: a review with emphasis on the role of cytopathology. Cancer Cytopathol 2020; 128 (07) 440-451
    CrossrefPubMedGoogle Scholar